New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.
For practice leadership, it’s important to address the situation in a way that supports both the manager and the team when doctors unduly intervene on behalf of their favorite staff.